[1] 刘杜鹃,张可佳,丁玉红,等.病理性瘢痕综合治疗的研究进展[J].中国老年学杂志,2013,33(7):1731-1733. [2] 赵贤忠,孙记燕,葛永亮,等.瘢痕移除原位再生皮肤组织器官的研究[J].中国烧伤创疡杂志,2012,24(4):321. [3] 张凡,邝捷,潘靖,等.病理性瘢痕的评价与联合治疗方案的选择[J].中国美容医学,2012,21(15):2008-2009. [4] 王量,李世荣,陶灵,等.增生性瘢痕及瘢痕疙瘩的非手术治疗[J].中国美容整形外科杂志,2012,23(7):437-439. [5] 黄丽萍,张冷, 胡希军,等.病理性瘢痕的治疗策略[J].临床军医杂志,2012,40(2):487-490. [6] 刘文阁,金娟娟,张蓉,等.三种注射器注射治疗病理性瘢痕的疗效观察[J].中华医学美学美容杂志,2011,17(4):307-308. [7] Gurtner GC, Werner S, Barrandon Y,et al.Wound repair and regeneration.Nature. 2008;453(7193):314-321. [8] Larson BJ, Longaker MT, Lorenz HP.Scarless fetal wound healing: a basic science review.Plast Reconstr Surg. 2010; 126(4):1172-1180. [9] Timmers L, Lim SK, Arslan F,et al.Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium.Stem Cell Res. 2007;1(2):129-137. [10] Li L, Zhang Y, Li Y,et al. Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure.Transpl Int. 2008; 21(12):1181-1189. [11] Ortiz LA, Gambelli F, McBride C,et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.Proc Natl Acad Sci U S A. 2003;100(14):8407-8411. [12] Kim SY, Lee JH, Kim HJ,et al.Mesenchymal stem cell-conditioned media recovers lung fibroblasts from cigarette smoke-induced damage.Am J Physiol Lung Cell Mol Physiol. 2012;302(9):L891-908. [13] Jiang T, Kumbar SG, Nair LS, et al.Biologically active chitosan systems for tissue engineering and regenerative medicine.Curr Top Med Chem. 2008;8(4):354-364. [14] Sarrazy V, Billet F, Micallef L,et al.Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen. 2011;19 Suppl 1:s10-15. [15] Parekkadan B, Milwid JM.Mesenchymal stem cells as therapeutics.Annu Rev Biomed Eng. 2010 ;12:87-117. [16] Németh K, Leelahavanichkul A, Yuen PS,et al.Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.Nat Med. 2009; 15(1):42-49. [17] Zanone MM, Favaro E, Miceli I,et al.Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.J Clin Endocrinol Metab. 2010;95(8):3788-3797. [18] Jackson WM, Nesti LJ, Tuan RS.Mesenchymal stem cell therapy for attenuation of scar formation during wound healing.Stem Cell Res Ther. 2012;3(3):20. [19] Li L, Zhang Y, Li Y,et al.Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure.Transpl Int. 2008; 21(12):1181-1189. [20] Chen L, Tredget EE, Wu PY,et al. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing.PLoS One. 2008; 3(4):e1886. [21] Smith AN, Willis E, Chan VT,et al.Mesenchymal stem cells induce dermal fibroblast responses to injury.Exp Cell Res. 2010;316(1):48-54. [22] Mayer H, Bertram H, Lindenmaier W,et al.Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation.J Cell Biochem. 2005;95(4):827-839. [23] Fu X, Fang L, Li X,et al.Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury.Wound Repair Regen. 2006;14(3):325-335. [24] Lozito TP, Kuo CK, Taboas JM,et al.Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix.J Cell Biochem. 2009;107(4): 714-722. [25] Yew TL, Hung YT, Li HY,et al.Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation.Cell Transplant. 2011;20(5):693-706. [26] Hsiao ST, Asgari A, Lokmic Z,et al.Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue.Stem Cells Dev. 2012;21(12):2189-2203. [27] Schievenbusch S, Strack I, Scheffler M,et al.Profiling of anti-fibrotic signaling by hepatocyte growth factor in renal fibroblasts.Biochem Biophys Res Commun. 2009;385(1): 55-61. [28] Inagaki Y, Higashi K, Kushida M,et al.Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin-7.Gastroenterology. 2008;134(4):1180-1190. [29] Mou S, Wang Q, Shi B,et al.Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.Kaohsiung J Med Sci. 2009;25(11):577-587. [30] Liechty KW, Kim HB, Adzick NS,et al.Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair.J Pediatr Surg. 2000;35(6):866-872. [31] Reitamo S, Remitz A, Tamai K,et al.Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts.J Clin Invest. 1994;94(6): 2489-2492. [32] Bevan D, Gherardi E, Fan TP,et al.Diverse and potent activities of HGF/SF in skin wound repair.J Pathol. 2004; 203(3):831-838. [33] Moore KW, de Waal Malefyt R, Coffman RL,et al. Interleukin-10 and the interleukin-10 receptor.Annu Rev Immunol. 2001;19:683-765. [34] Sato Y, Ohshima T, Kondo T. Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing.Biochem Biophys Res Commun. 1999;265(1): 194-199. [35] Gruber R, Kandler B, Holzmann P,et al.Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells.Tissue Eng.2005;11(5-6):896-903. [36] Kaigler D, Krebsbach PH, Polverini PJ,et al. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells.Tissue Eng.2003;9(1): 95-103. [37] Kato J, Tsuruda T, Kita T,et al.Adrenomedullin: a protective factor for blood vessels.Arterioscler Thromb Vasc Biol. 2005; 25(12):2480-2487. [38] Renault MA, Roncalli J, Tongers J,et al.The Hedgehog transcription factor Gli3 modulates angiogenesis.Circ Res. 2009;105(8):818-826. |